Atlas Trials

Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma

Clinical trial NCT00383851 · UNKNOWN

Trial details

NCT number
NCT00383851
Sponsor
Attenuon
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Melanoma
Start date
2006-09-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.